Bryostatins: biological context and biotechnological prospects.

@article{TrindadeSilva2010BryostatinsBC,
  title={Bryostatins: biological context and biotechnological prospects.},
  author={Amaro E Trindade-Silva and Grace Lim-Fong and Koty Sharp and Margo G. Haygood},
  journal={Current opinion in biotechnology},
  year={2010},
  volume={21 6},
  pages={
          834-42
        }
}
Bryostatins are a family of protein kinase C modulators that have potential applications in biomedicine. Found in miniscule quantities in a small marine invertebrate, lack of supply has hampered their development. In recent years, bryostatins have been shown to have potent bioactivity in the central nervous system, an uncultivated marine bacterial symbiont has been shown to be the likely natural source of the bryostatins, the bryostatin biosynthetic genes have been identified and characterized… 

Figures, Tables, and Topics from this paper

Marine natural products: Bryostatins in preclinical and clinical studies
TLDR
Bryostatin's anticancer activity has been proved against various cancer types and their significant antineoplastic activity against several tumor types has also been established and described.
The Phylum Bryozoa: From Biology to Biomedical Potential
TLDR
This review collates all currently available chemoecological data about bryozoans and lists potential applications/benefits for human health with particular attention to viral, brain, and parasitic diseases.
Microbial natural products: molecular blueprints for antitumor drugs
TLDR
This review describes only a handful of exemplary natural products and their derivatives as well as those that have served as elegant blueprints for the development of novel synthetic structures that are either currently in use or in clinical or preclinical trials together with some of their earlier analogs in some cases whose failure to proceed aided in the derivation of later compounds.
The expanding role of marine microbes in pharmaceutical development.
TLDR
An example of the karlotoxin class of compounds isolated from the dinoflagellate Karlodinium veneficum reveals a significant environmental impact, but also provides opportunities to construct new molecules for the control of cancer and serum cholesterol assisted by tools associated with rational drug design.
[Microbial secondary metabolites as inhibitors of pharmaceutically important transferases and oxidoreductases].
  • B. Eva, Sturdíková Mária
  • Medicine
    Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
  • 2012
TLDR
The new knowledge about mechanisms of the action and enzyme inhibitors in the field of enzymology gives space in drug discovery and development of safer and more effective pharmacotherapy.
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV
TLDR
A total synthesis of bryostatin 1 that proceeds in 29 total steps, collectively produces grams of material, and can be scaled to meet clinical needs (~20 grams per year), opens broad, facile, and efficient access to derivatives and potentially superior analogs.
Marine-Derived Anticancer Compounds
TLDR
This chapter gives useful information about the anticancer marine compounds, which have recently entered into the marketplace or currently are in the stages of preclinical and clinical development.
“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo
TLDR
The first in vivo validation that the bryostatin analog, picolog, is a potential therapeutic agent for the treatment of cancer and other diseases is provided.
Bioactive Compounds from Marine Heterobranchs
TLDR
Heterobranch molluscs are extremely interesting in regard to the study of marine natural products in terms of both chemical ecology and biotechnology studies, providing many leads for further detailed research in these fields in the near future.
Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity
TLDR
This study illustrates the application of function-oriented synthesis to the design and synthesis of functional analogs of the bryostatin marine natural products, specifically directed at exploring the activity-determining role of brystatin A-ring functionality on PKC affinity and selectivity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina.
TLDR
These deterrent bryostatins represent the first example from the marine environment of a microbial symbiont producing an antipredator defense for its host.
bryA: an unusual modular polyketide synthase gene from the uncultivated bacterial symbiont of the marine bryozoan Bugula neritina.
TLDR
A large modular polyketide synthase (PKS) gene complex from "Candidatus Endobugula sertula" is cloned and one gene, bryA, is characterized, which is proposed to synthesize a portion of the pharmacologically active part of brystatin and may be useful in semisynthesis of clinically useful bryostatin analogs.
Evidence for the Biosynthesis of Bryostatins by the Bacterial Symbiont “Candidatus Endobugula sertula” of the BryozoanBugula neritina
TLDR
This study demonstrates that it may be possible to clone bryostatin genes from B. neritina directly and use these to produce brystatins in heterologous host bacteria.
New approaches to the total synthesis of the bryostatin antitumor macrolides.
TLDR
An overview of various bryostatin total syntheses for the period 2001-2009 is given, since detailed reviews already exist on brystatin total synthesis work and biology up to this time.
Impact of environmental conditions on the marine natural product bryostatin 1
TLDR
The results demonstrate that natural conditions transform bryostatin to a number of structures, including one with a molar mass of 806 Da, which has been previously identified in the sediment collected from the Gulf of Mexico.
In vivo and in vitro trans-acylation by BryP, the putative bryostatin pathway acyltransferase derived from an uncultured marine symbiont.
TLDR
Biochemical characterization demonstrated that BryP catalyzes selective malonyl-CoA acylation of native and heterologous acyl carrier proteins and complete PKS modules in vitro, and provides the first biochemical evidence of the functionality of the bry cluster.
Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula".
TLDR
Gene sequences from an Atlantic sample matched sequences from the California chemotype M colonies, suggesting that this type may be cosmopolitan due to transport on boat hulls, and indicates that the chemotypes represent different species.
Identification of the putative bryostatin polyketide synthase gene cluster from "Candidatus Endobugula sertula", the uncultivated microbial symbiont of the marine bryozoan Bugula neritina.
TLDR
As "E. sertula" is to date uncultured, heterologous expression of this biosynthetic gene cluster has the potential of producing the bioactive bryostatins in large enough quantities for development into a pharmaceutical.
Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.
TLDR
Biological assays reveal a crucial role for substitution in the bryostatin 1 A-ring in conferring those responses which are characteristic of brystatin 1 and distinct from those observed with PMA.
Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: process developments and economics.
  • D. Mendola
  • Medicine, Biology
    Biomolecular engineering
  • 2003
TLDR
The development of two in-sea aquaculture systems designed and engineered for production of large quantities of biomass for two species of marine invertebrates desired for their natural product chemical constituents are described.
...
1
2
3
4
5
...